PCOS Support
Natural health product licensed in Canada
- Licence holder
- Les Emballages Façoteck
- NPN or DIN-HM
- 80129747
- Status
- Active licence
- Licence date
- 26 February 2024
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| D-Chiro-inositol Source : D-Chiro-inositol | 50 mg | Not calculated |
| Myo-inositol Source : Inositol | 2,000 mg | Not calculated |
| Folate Source : L-5 Méthyltétrahydrofolate, sel de calcium | 200 microgram | Not calculated |
| 3,3'-Diindolylméthane Source : 3,3'-diindolylméthane | 100 mg | Not calculated |
Non-medicinal ingredients
Poudre de bambou
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | minimum: 18 years | 2 Portions | 1 Time Unit TBA |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps reduce the severity and duration of symptoms associated with recurrent breast pain (cyclical mastalgia). Helps to support/promote healthy estrogen metabolism/balance. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/Provides (an) antioxidant(s). Helps in the management of polycystic ovarian syndrome (PCOS) by helping to restore normal ovarian function. Helps to restore ovulation and oocyte quality and to normalize menstrual cycle irregularities. Helps in the management of PCOS by reducing oxidative stresses. Helps in the management of PCOS's hormonal and metabolic conditions by promoting healthy glucose metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80129747
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.